Oxidized low-density lipoproteins induced inflammatory process during atherogenesis with aging

被引:2
|
作者
Larbi, A
Khalil, A
Douziech, N
Guérard, KP
Fulop, TS
机构
[1] Univ Sherbrooke, Inst Geriatr, Ctr Rech Vieillissement, Sherbrooke, PQ J1H 4C4, Canada
[2] Univ Sherbrooke, Fac Med, Serv Geriatr, Sherbrooke, PQ J1H 5N4, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
oxLDL; inflammation; atherosclerosis; aging;
D O I
10.1016/j.radphyschem.2004.02.010
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Atherosclerosis is a chronic disease developing through decades with two life-threatening complications: myocardial infarction and stroke. Oxidized low-density lipoproteins (oxLDL) produced by oxidative modifications of LDL in the subendothelial space have been demonstrated to be critically involved in atherogenesis through their intensive pro-inflammatory activity. Recently, it was shown that oxLDL have an apoptosis-inducing effect in T cells depending on time and degree of oxidation. The goal of the current study, is to elucidate the molecular mechanisms underlying the apoptotic-inducing effects of oxLDL on T lymphocytes. T cells of young and elderly subjects were incubated for various periods of time with LDL oxidized to various degrees. The proliferation, the apoptosis, the MAPK ERK1/2 activation and the expression of the Bcl-2 protein family members were measured upon different LDL treatments. Thus, more the LDL are oxidized more they induce apoptosis and this effect is highly accentuated with aging. The oxLDL decrease the activation of the surviving molecule ERK1/2 and modulate the ratio of Bax/Bcl-2 towards a pro-apoptotic profile, which is also accentuated with aging. These results partly explain why atherosclerosis is increasing with aging concomitantly to its complications. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:387 / 397
页数:11
相关论文
共 50 条
  • [1] OXIDIZED LOW-DENSITY LIPOPROTEINS AND ATHEROGENESIS
    LEAKE, DS
    BRITISH HEART JOURNAL, 1993, 69 (06): : 476 - 478
  • [2] OXIDIZED LOW-DENSITY LIPOPROTEINS IN ATHEROGENESIS - POSSIBLE MECHANISMS OF ACTION
    WEISSER, B
    LOCHER, R
    MENGDEN, T
    SACHINIDIS, A
    VETTER, W
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S4 - S7
  • [3] Oxidation of low-density lipoproteins and atherogenesis
    Dejager, S
    Chapman, J
    OCL-OLEAGINEUX CORPS GRAS LIPIDES, 1996, 3 (03): : 195 - 199
  • [4] OXIDIZED LOW-DENSITY LIPOPROTEINS INDUCED MICROVASCULAR DYSFUNCTION
    LIAO, LX
    GRANGER, DN
    FASEB JOURNAL, 1995, 9 (03): : A36 - A36
  • [5] THE ROLE OF OXIDIZED LOW-DENSITY LIPOPROTEINS AND AUTOANTIBODIES TO THEM IN ATHEROGENESIS IN PATIENTS WITH CORONARY ATHEROSCLEROSIS
    Shogenova, M.
    Karpov, A.
    Zhetisheva, R.
    Masenko, V.
    Naumov, V.
    ATHEROSCLEROSIS, 2016, 252 : E171 - E172
  • [6] ROLE OF LOW-DENSITY AND HIGH-DENSITY LIPOPROTEINS IN ATHEROGENESIS
    ASSMANN, G
    SCHRIEWER, H
    NUTRITION AND METABOLISM, 1980, 24 : 19 - 25
  • [7] Circulating Oxidized Low-Density Lipoproteins and Antibodies against Oxidized Low-Density Lipoproteins as Potential Biomarkers of Colorectal Cancer
    Diakowska, Dorota
    Grabowski, Krzysztof
    Nienartowicz, Miroslaw
    Zarebski, Pawel
    Fudalej, Kamila
    Markocka-Maczka, Krystyna
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2015, 2015
  • [8] Putting low-density lipoproteins at center stage in atherogenesis
    Sniderman, AD
    Pedersen, T
    Kjekshus, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (01): : 64 - +
  • [9] Oxidized low density lipoproteins in atherogenesis: Role of dietary modification
    Reaven, PD
    Witztum, JL
    ANNUAL REVIEW OF NUTRITION, 1996, 16 : 51 - 71
  • [10] Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?
    Orekhov, Alexander
    Sukhorukov, Vasily
    Melnichenko, Alexandra
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (42) : 6909 - 6910